2014
DOI: 10.1021/ml400528y
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists

Abstract: In connection with a program directed at potent and balanced dual NK 1 /NK 3 receptor ligands, a focused exploration of an original class of peptidomimetic derivatives was performed. The rational design and molecular hybridization of a novel phenylalanine core series was achieved to maximize the in vitro affinity and antagonism at both human NK 1 and NK 3 receptors. This study led to the identification of a new potent dual NK 1 /NK 3 antagonist with pK i values of 8.6 and 8.1, respectively.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 62 publications
0
8
0
Order By: Relevance
“…[299] The obtained compound 317 showed activity as a new potent dual NK 1 /NK 3 (neurokinin 1 and neurokinin 3) antagonist with pK i values of 8.6 and 8.1, respectively. [300] Performance index of this compound in relation to neurokinin 3 is better than the similar data of the previously synthesized NK 3 R antagonist, compound 319 ( Figure 2). [301] Both NK 1 and NK 3 receptors are localized in the corticolimbic structures of the brain.…”
Section: Some Biologically Active Compounds With a Spiro Carbon Centermentioning
confidence: 70%
“…[299] The obtained compound 317 showed activity as a new potent dual NK 1 /NK 3 (neurokinin 1 and neurokinin 3) antagonist with pK i values of 8.6 and 8.1, respectively. [300] Performance index of this compound in relation to neurokinin 3 is better than the similar data of the previously synthesized NK 3 R antagonist, compound 319 ( Figure 2). [301] Both NK 1 and NK 3 receptors are localized in the corticolimbic structures of the brain.…”
Section: Some Biologically Active Compounds With a Spiro Carbon Centermentioning
confidence: 70%
“…Our initial proposal to perform a hydroboration under numerous reaction conditions were discouraging (Table 1, entries 1–3) 14. Radical bromination conditions adopted from the literature only gave dibromo adducts (entry 4),19 which were inert to any attempts at pyridone installation. Although epoxidation with in situ generated DMDO could afford two inseparable stereoisomers (d.r.…”
Section: Methodsmentioning
confidence: 99%
“…3,1-Benzoxazine derivatives show anticonvulsant [ 1 ], herbicidal [ 2 ], fungicidal [ 3 , 4 ], and anticancer activity [ 5 ], and some are potent progesterone receptor (PR) agonists [ 6 ] or DNA-binding antitumor agents [ 7 ]. 3,1-Benzoxazinones exhibit antihypertensive [ 8 ] and antiproliferative activities [ 9 ], or are potent PR agonists/antagonists [ 10 , 11 ], potent human leukocyte elastase inhibitors [ 12 ], serine protease inhibitors [ 13 , 14 , 15 ], long chain fatty acid elongase 6 inhibitors [ 16 ], NK 1 /NK 3 receptor antagonists [ 17 ], α-chymotrypsin inhibitors [ 18 ], mineralocorticoid receptors antagonists [ 19 ], and are even used as anti-HIV-1 reverse transcriptase inhibitors [ 20 , 21 ]. Therefore, the synthesis of 3,1-benzoxazines and 3,1-benzoxazinone has attracted considerable interest.…”
Section: Introductionmentioning
confidence: 99%